KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Travere Therapeutics (TVTX) Consolidated Net Income (2016 - 2024)

Historic Consolidated Net Income for Travere Therapeutics (TVTX) over the last 16 years, with Q4 2024 value amounting to $4000.0.

  • Travere Therapeutics' Consolidated Net Income rose 10025.36% to $4000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $4000.0, marking a year-over-year increase of 10015.77%. This contributed to the annual value of -$915000.0 for FY2024, which is 10034.54% down from last year.
  • Latest data reveals that Travere Therapeutics reported Consolidated Net Income of $4000.0 as of Q4 2024, which was up 10025.36% from -$100000.0 recorded in Q3 2024.
  • Over the past 5 years, Travere Therapeutics' Consolidated Net Income peaked at $240.0 million during Q3 2023, and registered a low of -$121.6 million during Q4 2020.
  • Over the past 5 years, Travere Therapeutics' median Consolidated Net Income value was -$101500.0 (recorded in 2024), while the average stood at -$3.5 million.
  • In the last 5 years, Travere Therapeutics' Consolidated Net Income crashed by 657439.9% in 2021 and then skyrocketed by 156569.03% in 2023.
  • Quarter analysis of 5 years shows Travere Therapeutics' Consolidated Net Income stood at -$121.6 million in 2020, then rose by 27.01% to -$88.8 million in 2021, then surged by 122.32% to $19.8 million in 2022, then plummeted by 107.96% to -$1.6 million in 2023, then surged by 100.25% to $4000.0 in 2024.
  • Its Consolidated Net Income stands at $4000.0 for Q4 2024, versus -$100000.0 for Q3 2024 and -$757000.0 for Q2 2024.